Beyond urate lowering: neuroprotective potential of Allopurinol
Vyshnavy Balendra · 2025
Read Beyond urate lowering: neuroprotective potential of Allopurinol by Vyshnavy Balendra (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709900.txt.
Description
Vyshnavy Balendra reviews whether a gout drug can shield the brain in a 2025 paper. Allopurinol blocks an enzyme that makes uric acid, and that same enzyme pours out free radicals. The radical flood is tied to Alzheimer's disease, and the enzyme runs hot in inflamed brains. Balendra searched a decade of English-language studies on the drug, the enzyme, and the disease.
Cell studies linked high enzyme levels to more support-cell growth and fewer surviving neurons. Animal work pointed the same way: taming the enzyme calmed radical damage. Human proof remains the missing piece, and the review says so. An old, cheap, well-known drug with a plausible brain benefit is exactly the kind that deserves a proper trial.
Catalog record
| CREATOR | Vyshnavy Balendra |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |